マーケットレポート詳細

医薬品添加剤の世界市場:製品別、機能別2027年予測

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) - Global Forecast to 2027

出版元:MarketsandMarkets   出版元について
発行年:2022年6月
定価 :Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文373ページになります。
商品コード:MAM2958

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

医薬品添加剤の世界市場規模は2022年で86億ドル、2027年に115億ドル、市場の平均年成長率は5.9%に達すると予測されています。

レポートは医薬品添加剤の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(製品別市場、機能別市場、等 )を中心に構成されています。また競合状況、主要企業情報(13社)、市場ダイナミクス、市場シェア分析、競合状況
などの分析も加味し、医薬品添加剤市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆医薬品添加剤の世界市場予測2020-2027年

・市場規模(US$)

◆製品別、市場-2027年

<有機化学品>
油脂化学
・脂肪族アルコール
・ミネラルステアリン酸
・グリセリン
・その他油脂化学

炭水化物
・糖類
-砂糖
-糖アルコール
-人工甘味料
・セルロース
-微結晶セルロース
-セルロースエーテル
-CMC、クロスカルメロースナトリウム
-セルロースエステル
・デンプン
-変性デンプン
-乾燥デンプン
-加工デンプン

石油化学品
・グリコール
・ポビドン
・ミネラル炭化水素
・アクリルポリマー
・その他石油化学品

タンパク質
その他有機化学品

<無機化学品>
リン酸カルシウム
金属酸化物
岩塩
炭酸カルシウム
硫酸カルシウム

<その他化学品>
※(市場規模US$)

◆機能別、市場-2027年

・充填剤および希釈剤
・懸濁、増粘剤
・コーティング剤
・バインダー
・香料、甘味料
・崩壊剤
・着色剤
・潤滑剤、流動促進剤
・防腐剤
・乳化剤
・その他
※(市場規模US$)

◆形状別、市場-2027年

経口剤
・錠剤
・カプセル
-ハードゼラチンカプセル
-ソフトゼラチンカプセル
・液体製剤
局所製剤
非経口製剤
その他形状
※(市場規模US$)

◆主要国地域別市場-2027年

欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
北米
・米国、カナダ
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19の影響分析
・貿易データ
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・特許分析
・規制分析
・ファイブフォース分析
・市場シェア分析
・競合状況

◆医薬品添加剤の主要企業プロフィール動向

・INTERNATIONAL FLAVORS & FRAGRANCES INC.
・ASHLAND GLOBAL HOLDINGS INC
・EVONIK INDUSTRIES AG
・BASF SE
・KERRY GROUP PLC
・ROQUETTE FRÈRES
・MERCK KGAA
・ASSOCIATED BRITISH FOODS PLC
・ARCHER DANIELS MIDLAND (ADM) COMPANY
・WACKER CHEMIE AG
・AIR LIQUIDE SA
・DOW CHEMICALS
・LUBRIZOL CORPORATION    

(その他企業)
・COLORCON, INC        
・DMV-FONTERRA EXCIPIENTS GMBH & CO. KG            
・INNOPHOS HOLDINGS, INC  
・JRS PHARMA GMBH & CO. KG
・FINAR LIMITED          
・MEGGLE GMBH & CO. KG      
・富士化学工業株式会社
・CAPTISOL     
・IDEAL CURES PVT. LTD.         
・COREL PHARMA CHEM          
・BIOGRUND GMBH     
・NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.
(全373頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1      INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.2.1               INCLUSIONS AND EXCLUSIONS
1.3            MARKET SCOPE
1.3.1               MARKETS COVERED   58
・     FIGURE 1             PHARMACEUTICAL EXCIPIENTS MARKET
1.3.2               YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY
1.5            LIMITATIONS
1.6            STAKEHOLDERS
1.7            SUMMARY OF CHANGES

2      RESEARCH METHODOLOGY

2.1            RESEARCH DATA
・     FIGURE 2             RESEARCH DESIGN   61
2.1.1               SECONDARY DATA
2.1.2               PRIMARY DATA
・     FIGURE 3             BREAKDOWN OF PRIMARIES BY RESPONDENT, DESIGNATION, AND REGION: PHARMACEUTICAL EXCIPIENTS MARKET
2.2            MARKET ESTIMATION METHODOLOGY
・     FIGURE 4             PHARMACEUTICAL EXCIPIENTS MARKET SIZE ESTIMATION
(SUPPLY-SIDE ANALYSIS), 2021
・     FIGURE 5             MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
2.2.1               INSIGHTS FROM PRIMARY EXPERTS
・     FIGURE 6             MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3            MARKET GROWTH RATE PROJECTIONS
・     FIGURE 7             PHARMACEUTICAL EXCIPIENTS MARKET (SUPPLY SIDE): CAGR PROJECTIONS
・     FIGURE 8             PHARMACEUTICAL EXCIPIENTS MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.3.1               DATA TRIANGULATION
・     FIGURE 9             DATA TRIANGULATION METHODOLOGY
2.4            RESEARCH ASSUMPTIONS
2.4.1               COVID-19 ASSUMPTIONS
2.5            RISK ANALYSIS

3      EXECUTIVE SUMMARY

・     FIGURE 10           PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)
・     FIGURE 11           PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2022 VS. 2027 (USD MILLION)
・     FIGURE 12           PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2022 VS. 2027 (USD MILLION)
・     FIGURE 13           GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL EXCIPIENTS MARKET

4      PREMIUM INSIGHTS

4.1            PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW
・     FIGURE 14           GROWING PHARMACEUTICALS INDUSTRY, COUPLED WITH ADVANCEMENTS IN FUNCTIONAL EXCIPIENTS, ARE KEY FACTORS DRIVING MARKET GROWTH
4.2            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION AND COUNTRY (2020)
・     FIGURE 15           ORAL FORMULATIONS ACCOUNTED FOR THE LARGEST SHARE OF
THE ASIA PACIFIC MARKET IN 2021
4.3            PHARMACEUTICALS EXCIPIENTS MARKET SHARE, BY PRODUCT, 2022 VS. 2027
・     FIGURE 16           ORGANIC CHEMICALS SEGMENT WILL CONTINUE TO DOMINATE
THE MARKET IN 2027
4.4            PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION, 2022
・     FIGURE 17           ORAL FORMULATIONS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2022
4.5            PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・     FIGURE 18           ASIA PACIFIC COUNTRIES TO SHOW THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5      MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
・     FIGURE 19           PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・     TABLE 1               PHARMACEUTICAL EXCIPIENTS MARKET: IMPACT ANALYSIS
5.2.1               DRIVERS
5.2.1.1             GROWTH OF THE PHARMACEUTICALS MARKET BACKED BY FUNCTIONAL EXCIPIENTS
・     FIGURE 20           GLOBAL PHARMACEUTICAL DRUG SALES (2008–2022)
5.2.1.2             SURGE IN THE GENERICS MARKET
・     TABLE 2               DRUG PATENT EXPIRY, BY YEAR
5.2.1.3             INCREASING UPTAKE OF BIOPHARMACEUTICALS
5.2.1.4             RISING ADOPTION OF ORPHAN DRUGS
・     FIGURE 21           INCREASING PENETRATION OF ORPHAN DRUGS (2010–2024)
・     FIGURE 22           RISING NUMBER OF ORPHAN INDICATIONS APPROVED IN THE US
5.2.2               RESTRAINTS
5.2.2.1             COST AND TIME-INTENSIVE DRUG DEVELOPMENT PROCESS
5.2.2.2             INCREASING REGULATORY STRINGENCY
5.2.3               OPPORTUNITIES
5.2.3.1             MULTIFUNCTIONAL EXCIPIENTS
・     TABLE 3               MULTIFUNCTIONAL EXCIPIENTS
5.2.3.2             SHIFTING FOCUS OF PHARMACEUTICAL MANUFACTURING TO EMERGING COUNTRIES
5.2.3.3             GROWTH IN THE BIOSIMILARS MARKET
5.2.4               CHALLENGES
5.2.4.1             SAFETY AND QUALITY CONCERNS
5.2.4.2             CHANGING TRADE POLICIES
5.2.5               INDUSTRY TRENDS  86
5.2.5.1             RISING DEMAND FOR CO-PROCESSED EXCIPIENTS
・     TABLE 4               MARKETED CO-PROCESSED EXCIPIENTS
5.2.5.2             IMPROVING EXCIPIENT CAPABILITIES USING NANOTECHNOLOGY
5.2.5.3             INCREASING USE OF DIRECT COMPRESSION IN ORAL DOSAGE FORMULATIONS
5.2.5.4             PHARMACEUTICAL EXCIPIENTS INFLUENCING THE COST OF PRODUCTION
5.3            RANGES/SCENARIO
・     FIGURE 23           SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE PHARMACEUTICAL EXCIPIENTS MARKET
5.4            IMPACT OF COVID-19 ON THE PHARMACEUTICAL EXCIPIENTS MARKET
・     FIGURE 24           INCREASE IN REVENUE, BY QUARTER
・     FIGURE 25           COVID-19 IMPACT ON SECTIONS OF THE PHARMACEUTICAL INDUSTRY
・     FIGURE 26           PHARMACEUTICAL EXCIPIENTS MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021
5.5            TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
・     FIGURE 27           REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENTS PROVIDERS
5.6            TRADE DATA
5.6.1               SUCROSE
5.6.2               PREPARED BINDERS FOR MOLDS/CORES, CHEMICAL PRODUCTS, AND PREPARATION FOR CHEMICAL INDUSTRIES
5.6.3               MANNITOL (ACYCLIC ALCOHOLS & THEIR DERIVATIVES)
5.6.4               CELLULOSE
5.7            INDICATIVE PRICING MODEL ANALYSIS
5.7.1               US
5.7.2               CHINA
5.7.3               INDIA
5.8            VALUE CHAIN ANALYSIS
・     FIGURE 28           VALUE CHAIN ANALYSIS OF THE PHARMACEUTICAL EXCIPIENTS MARKET
5.9            SUPPLY CHAIN ANALYSIS
・     FIGURE 29           PHARMACEUTICAL EXCIPIENTS MARKET: SUPPLY CHAIN ANALYSIS
5.10          ECOSYSTEM ANALYSIS
・     FIGURE 30           ECOSYSTEM ANALYSIS: PHARMACEUTICAL EXCIPIENTS MARKET
・     TABLE 5               SUPPLY CHAIN ECOSYSTEM
5.11          PATENT ANALYSIS
・     FIGURE 31           PATENT APPLICATIONS FOR THE PHARMACEUTICAL EXCIPIENTS MARKET, JANUARY 2012–MAY 2022
・     TABLE 6               INDICATIVE LIST OF PATENTS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
5.12          KEY CONFERENCES AND EVENTS, 2022–2023
・     TABLE 7               CONFERENCES, 2022–2023
5.13          REGULATORY ANALYSIS
5.13.1             NORTH AMERICA
5.13.1.1           US
5.13.1.2           CANADA
5.13.2             EUROPE
5.13.3             ASIA PACIFIC
5.13.3.1           JAPAN
5.13.3.2           CHINA
5.13.3.3           INDIA
5.14          PORTER’S FIVE FORCES ANALYSIS
・     TABLE 8               PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.14.1             THREAT OF NEW ENTRANTS
5.14.2             THREAT OF SUBSTITUTES
5.14.3             BARGAINING POWER OF BUYERS
5.14.4             BARGAINING POWER OF SUPPLIERS
5.14.5             DEGREE OF COMPETITION
5.15          KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1             KEY STAKEHOLDERS IN COMPANIES AND THEIR INFLUENCE ON THE BUYING PROCESS
・     FIGURE 32           INFLUENCE OF COMPANY STAKEHOLDERS IN THE BUYING PROCESS OF PHARMACEUTICAL EXCIPIENTS PRODUCTS
5.15.2             KEY BUYING CRITERIA FOR PHARMACEUTICAL EXCIPIENT PRODUCTS AMONG END USERS
・     FIGURE 33           KEY BUYING CRITERIA FOR END USERS

6      PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

6.1            INTRODUCTION
・     TABLE 9               PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
6.2            ORGANIC CHEMICALS
・     TABLE 10             PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 11             PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 12             NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 13             EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 14             ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1               OLEOCHEMICALS
・     TABLE 15             OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 16             OLEOCHEMICALS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 17             NORTH AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 18             EUROPE: OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 19             ASIA PACIFIC: OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.1             FATTY ALCOHOLS
6.2.1.1.1             FATTY ALCOHOLS ARE WIDELY USED AS NONIONIC SURFACTANTS DUE TO THEIR AMPHIPATHIC NATURE—A MAJOR DRIVER FOR MARKET GROWTH
・     TABLE 20             FATTY ALCOHOLS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 21             NORTH AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 22             EUROPE: FATTY ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 23             ASIA PACIFIC: FATTY ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.2             MINERAL STEARATES
6.2.1.2.1             WIDE USE OF MAGNESIUM STEARATES AS EXCIPIENTS IN NUTRACEUTICAL AND PHARMACEUTICAL FORMULATIONS TO DRIVE MARKET GROWTH
・     TABLE 24             METAL STEARATES MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 25             NORTH AMERICA: METAL STEARATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 26             EUROPE: METAL STEARATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 27             ASIA PACIFIC: METAL STEARATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.1.3             GLYCERIN
6.2.1.3.1             EXTENSIVE APPLICATIONS OF GLYCERIN TO DRIVE MARKET GROWTH
・     TABLE 28             GLYCERIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 29             NORTH AMERICA: GLYCERIN MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 30             EUROPE: GLYCERIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 31             ASIA PACIFIC: GLYCERIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.4             OTHER OLEOCHEMICALS
・     TABLE 32             OTHER OLEOCHEMICALS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 33             NORTH AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 34             EUROPE: OTHER OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 35             ASIA PACIFIC: OTHER OLEOCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2               CARBOHYDRATES
・     TABLE 36             CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 37             CARBOHYDRATES MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 38             NORTH AMERICA: CARBOHYDRATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 39             EUROPE: CARBOHYDRATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 40             ASIA PACIFIC: CARBOHYDRATES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.1             SUGARS
・     TABLE 41             SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 42             SUGARS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 43             NORTH AMERICA: SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 44             EUROPE: SUGARS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 45             ASIA PACIFIC: SUGARS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.1.1             ACTUAL SUGARS
6.2.2.1.1.1          GROWING USE OF ACTUAL SUGARS IN PEDIATRIC FORMULATIONS DRIVES THE MARKET GROWTH
・     TABLE 46             ACTUAL SUGARS MARKET, BY REGION, 2020–2027 (USD MILLION)

・     TABLE 47             NORTH AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 48             EUROPE: ACTUAL SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 49             ASIA PACIFIC: ACTUAL SUGARS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.1.2             SUGAR ALCOHOLS
6.2.2.1.2.1          MANNITOL TO SHOW THE HIGHEST GROWTH IN THE MARKET FOR SUGAR ALCOHOLS    127
・     TABLE 50             SUGAR ALCOHOLS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 51             NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 52             EUROPE: SUGAR ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 53             ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.1.3             ARTIFICIAL SWEETENERS
6.2.2.1.3.1          ASPARTAME IS THE MOST USED ARTIFICIAL SWEETENER
・     TABLE 54             ARTIFICIAL SWEETENERS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 55             NORTH AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 56             EUROPE: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 57             ASIA PACIFIC: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.2             CELLULOSE
・     TABLE 58             CELLULOSE MARKET BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 59             CELLULOSE MARKET BY REGION, 2020–2027 (USD MILLION)
・     TABLE 60             NORTH AMERICA: CELLULOSE MARKET BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 61             EUROPE: CELLULOSE MARKET BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 62             ASIA PACIFIC: CELLULOSE MARKET BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.2.1             MICROCRYSTALLINE CELLULOSE
6.2.2.2.1.1          MICROCRYSTALLINE CELLULOSE IS THE MOST WIDELY USED EXCIPIENT IN THE DIRECT COMPRESSION METHOD FOR ・     TABLETS
・     TABLE 63             MICROCRYSTALLINE CELLULOSE MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 64             NORTH AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 65             EUROPE: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 66             ASIA PACIFIC: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2.2             CELLULOSE ETHERS
6.2.2.2.2.1          CELLULOSE ETHERS ARE EFFECTIVE EVEN AT A LOWER CONCENTRATION
・     TABLE 67             CELLULOSE ETHERS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 68             NORTH AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 69             EUROPE: CELLULOSE ETHERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 70             ASIA PACIFIC: CELLULOSE ETHERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.2.3             CMC & CROSCARMELLOSE SODIUM
6.2.2.2.3.1          MULTIPLE ADVANTAGES OF CMC AND CROSCARMELLOSE SODIUM MAKE THEM THE MOST WIDELY USED SUSPENDING AGENTS IN INJEC・     TABLE PREPARATIONS    136
・     TABLE 71             CMC & CROSCARMELLOSE SODIUM MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 72             NORTH AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 73             EUROPE: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 74             ASIA PACIFIC: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2.4             CELLULOSE ESTERS
6.2.2.2.4.1          CELLULOSE ESTERS ENABLE THE DELIVERY OF DRUGS IN CELLULAR MEMBRANES AND THE INTRACELLULAR MATRIX
・     TABLE 75             CELLULOSE ESTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 76             NORTH AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 77             EUROPE: CELLULOSE ESTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 78             ASIA PACIFIC: CELLULOSE ESTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.3             STARCH
・     TABLE 79             STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 80             STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 81             NORTH AMERICA: STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 82             EUROPE: STARCH MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 83             ASIA PACIFIC: STARCH MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.3.1             MODIFIED STARCH
6.2.2.3.1.1          MODIFIED STARCH IS WIDELY USED IN SUSTAINED-RELEASE ・     TABLETS DUE TO ITS COLD-WATER SWELLING AND GEL BARRIER FORMATION CAPABILITIES
・     TABLE 84             MODIFIED STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 85             NORTH AMERICA: MODIFIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 86             EUROPE: MODIFIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 87             ASIA PACIFIC: MODIFIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.3.2             DRIED STARCH
6.2.2.3.2.1          DRIED STARCH IS A STRONG BINDING AND COATING AGENT
・     TABLE 88             DRIED STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 89             NORTH AMERICA: DRIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 90             EUROPE: DRIED STARCH MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 91             ASIA PACIFIC: DRIED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.3.3             CONVERTED STARCH
6.2.2.3.3.1          CONVERTED STARCH IS USED AS A MOLECULAR ENCAPSULATION AGENT AND OFFERS ENHANCED SOLUBILITY AND STABILITY FOR DRUGS
・     TABLE 92             CONVERTED STARCH MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 93             NORTH AMERICA: CONVERTED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 94             EUROPE: CONVERTED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 95             ASIA PACIFIC: CONVERTED STARCH MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3               PETROCHEMICALS
・     TABLE 96             PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 97             PETROCHEMICALS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 98             NORTH AMERICA: PETROCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 99             EUROPE: PETROCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 100           ASIA PACIFIC: PETROCHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3.1             GLYCOLS
6.2.3.1.1             THE AVAILABILITY OF HIGHLY PURIFIED POLYETHYLENE GLYCOL TO ENHANCE STABILITY HAS DRIVEN THE DEMAND
・     TABLE 101           GLYCOLS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 102           NORTH AMERICA: GLYCOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 103           EUROPE: GLYCOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 104           ASIA PACIFIC: GLYCOLS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3.2             POVIDONES
6.2.3.2.1             RISING DEMAND FOR FAST-DISSOLVING ・     TABLETS IS EXPECTED TO PROPEL THE GROWTH OF THIS SEGMENT
・     TABLE 105           POVIDONES MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 106           NORTH AMERICA: POVIDONES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 107           EUROPE: POVIDONES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 108           ASIA PACIFIC: POVIDONES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3.3             MINERAL HYDROCARBONS
6.2.3.3.1             GROWING PREFERENCE FOR TOPICAL FORMULATIONS IN PAIN MANAGEMENT HAS SUPPORTED THE DEMAND FOR MINERAL HYDROCARBONS
・     TABLE 109           MINERAL HYDROCARBONS MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 110           NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 111           EUROPE: MINERAL HYDROCARBONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 112           ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3.4             ACRYLIC POLYMERS
6.2.3.4.1             WIDE USE OF ACRYLIC POLYMERS IN CONTROLLED-RELEASE DRUG FORMULATIONS TO DRIVE MARKET GROWTH
・     TABLE 113           ACRYLIC POLYMERS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 114           NORTH AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 115           EUROPE: ACRYLIC POLYMERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 116           ASIA PACIFIC: ACRYLIC POLYMERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.3.5             OTHER PETROCHEMICAL EXCIPIENTS
・     TABLE 117           OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 118           NORTH AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 119           EUROPE: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 120           ASIA PACIFIC: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4               PROTEINS
6.2.4.1             GROWING APPLICATIONS OF PROTEINS AS CARRIERS FOR MICROPARTICLES AND NANOPARTICLES TO DRIVE MARKET GROWTH
・     TABLE 121           PROTEINS MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 122           NORTH AMERICA: PROTEINS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 123           EUROPE: PROTEINS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 124           ASIA PACIFIC: PROTEINS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.5               OTHER ORGANIC CHEMICALS
・     TABLE 125           OTHER ORGANIC CHEMICALS MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 126           NORTH AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 127           EUROPE: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 128           ASIA PACIFIC: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3            INORGANIC CHEMICALS
・     TABLE 129           PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 130           PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 131           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION) 161
・     TABLE 132           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION) 162
・     TABLE 133           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION) 162
6.3.1               CALCIUM PHOSPHATE  162
6.3.1.1             CHEMICAL PURITY AND LOW INCOMPATIBILITY WITH DRUGS AID THEIR HIGH USAGE IN THE PHARMACEUTICAL INDUSTRY
・     TABLE 134           CALCIUM PHOSPHATE MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 135           NORTH AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 136           EUROPE: CALCIUM PHOSPHATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 137           ASIA PACIFIC: CALCIUM PHOSPHATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.2               METAL OXIDES
6.3.2.1             AVAILABILITY OF SILICON OXIDES IN THE HYDROPHOBIC, HYDROPHILIC, AND GRANULATED FORMS TO AID MARKET GROWTH
・     TABLE 138           METAL OXIDES MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 139           NORTH AMERICA: METAL OXIDES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 140           EUROPE: METAL OXIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 141           ASIA PACIFIC: METAL OXIDES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.3               HALITES
6.3.3.1             INCREASED UTILIZATION OF HALITES IN VACCINES AND CONTROLLED-RELEASE FORMULATIONS IS DRIVING THEIR DEMAND IN THE MARKET
・     TABLE 142           HALITES MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 143           NORTH AMERICA: HALITES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 144           EUROPE: HALITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 145           ASIA PACIFIC: HALITES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.4               CALCIUM CARBONATE  167
6.3.4.1             PROPERTIES SUCH AS SHORT DISINTEGRATION TIME AND EXCELLENT MECHANICAL STRENGTH FOR ORAL DOSAGE FORMULATIONS TO DRIVE THE MARKET
・     TABLE 146           CALCIUM CARBONATE MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 147           NORTH AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 148           EUROPE: CALCIUM CARBONATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 149           ASIA PACIFIC: CALCIUM CARBONATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.5               CALCIUM SULFATE  169
6.3.5.1             CALCIUM SULFATE IS A COST-EFFECTIVE, QUALITY-ENHANCING DILUENT FOR SOLID DOSAGE FORMS
・     TABLE 150           CALCIUM SULFATE MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 151           NORTH AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 152           EUROPE: CALCIUM SULFATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 153           ASIA PACIFIC: CALCIUM SULFATE MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3.6               OTHER INORGANIC CHEMICALS
・     TABLE 154           OTHER INORGANIC CHEMICALS MARKET, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 155           NORTH AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 156           EUROPE: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 157           ASIA PACIFIC: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.4            OTHER CHEMICALS
・     TABLE 158           PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 159           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 160           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 161           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)

7      PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

7.1            INTRODUCTION
・     TABLE 162           PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
7.2            FILLERS & DILUENTS
7.2.1               DILUENTS OFFER PROPERTIES SUCH AS IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO THE FINAL DOSE IN ・     TABLETS
・     TABLE 163           PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 164           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 165           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 166           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3            SUSPENDING & VISCOSITY AGENTS
7.3.1               SUSPENSIONS OFFER ADVANTAGES SUCH AS DRUG STABILITY AND TASTE MASKING
・     TABLE 167           PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 168           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 169           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 170           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4            COATING AGENTS
7.4.1               INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN THE PHARMA INDUSTRY TO DRIVE MARKET GROWTH
・     TABLE 171           PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 172           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 173           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 174           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5            BINDERS
7.5.1               BINDERS PROVIDE FLUIDITY AND COMPRESSIBILITY ESSENTIAL FOR ・     TABLET MANUFACTURING
・     TABLE 175           PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 176           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 177           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 178           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,
BY COUNTRY, 2020–2027 (USD MILLION)
7.6            FLAVORING AGENTS & SWEETENERS
7.6.1               FLAVORING AGENTS ARE USED TO IMPROVE THE PALATABILITY OF DRUGS
・     TABLE 179           PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 180           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 181           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 182           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.7            DISINTEGRANTS
7.7.1               DISINTEGRANTS CAUSE A RAPID BREAK-UP OF SOLID DOSAGE FORMS
・     TABLE 183           PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 184           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 185           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 186           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY COUNTRY, 2020–2027 (USD MILLION)
7.8            COLORANTS
7.8.1               COLORING AGENTS ARE USED IN HARD AND SOFT GELATIN CAPSULES, ・     TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS
・     TABLE 187           PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 188           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 189           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 190           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,
BY COUNTRY, 2020–2027 (USD MILLION)
7.9            LUBRICANTS & GLIDANTS
7.9.1               GLIDANTS IMPROVE THE FLOW PROPERTIES OF A FORMULATION BY REDUCING INTER-PARTICLE FRICTION AND COHESION
・     TABLE 191           PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 192           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 193           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 194           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2020–2027 (USD MILLION)
7.10          PRESERVATIVES
7.10.1             BENZYL ALCOHOL IS A WIDELY USED PRESERVATIVE IN THE PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY
・     TABLE 195           PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 196           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 197           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 198           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY COUNTRY, 2020–2027 (USD MILLION)
7.11          EMULSIFYING AGENTS
7.11.1             USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS HELPS INCREASE API BIOAVAILABILITY
・     TABLE 199           PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION, 2020–2027 (USD MILLION)

・     TABLE 200           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 192
・     TABLE 201           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 192
・     TABLE 202           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 193
7.12          OTHER FUNCTIONALITIES
・     TABLE 203           PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 204           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 205           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 206           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2020–2027 (USD MILLION)

8      PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION

8.1            INTRODUCTION
・     TABLE 207           PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
8.2            ORAL FORMULATIONS
・     TABLE 208           PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 209           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 197
・     TABLE 210           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 211           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 198
・     TABLE 212           PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)

8.2.1               ・     TABLETS
8.2.1.1             ・     TABLETS ARE THE MOST WIDELY USED DOSAGE FORMS
・     TABLE 213           TYPICAL COMPOSITION OF ・     TABLETS
・     TABLE 214           PHARMACEUTICAL EXCIPIENTS MARKET FOR ・     TABLETS, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 215           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ・     TABLETS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 216           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ・     TABLETS,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 217           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ・     TABLETS,
BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2               CAPSULES
・     TABLE 218           PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY REGION,
2020–2027 (USD MILLION)
・     TABLE 219           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 220           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 221           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,
BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 222           PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,
2020–2027 (USD MILLION)
8.2.2.1             HARD-GELATIN CAPSULES
8.2.2.1.1             EASE OF MANUFACTURING AND VERSATILITY ARE DRIVING THE GROWTH OF THE HARD-GELATIN CAPSULES MARKET
・     TABLE 223           HARD-GELATIN CAPSULES MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 224           NORTH AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 225           EUROPE: HARD-GELATIN CAPSULES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 226           ASIA PACIFIC: HARD-GELATIN CAPSULES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
8.2.2.2             SOFT-GELATIN CAPSULES
8.2.2.2.1             STABILITY CONCERNS WITH HIGHLY WATER-SOLUBLE COMPOUNDS AND COMPOUNDS SUSCEPTIBLE TO HYDROLYSIS HAVE RESTRICTED MARKET GROWTH
・     TABLE 227           SOFT-GELATIN CAPSULES MARKET, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 228           NORTH AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 229           EUROPE: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 230           ASIA PACIFIC: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
8.2.3               LIQUID FORMULATIONS
8.2.3.1             LIQUID FORMULATIONS REQUIRE NO DISSOLUTION TIME AND BOAST FASTER ABSORPTION FROM THE STOMACH THAN ・     TABLETS
・     TABLE 231           PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 232           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 207
・     TABLE 233           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 234           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 207
8.3            TOPICAL FORMULATIONS
8.3.1               ADVANTAGES OF TOPICAL DRUG DELIVERY ARE DRIVING THE DEMAND FOR EXCIPIENTS IN THIS SEGMENT
・     TABLE 235           PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 236           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 237           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 238           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4            PARENTERAL FORMULATIONS
8.4.1               EMERGENCE OF NEW BIOLOGICAL MOLECULES INCREASES THE DEMAND FOR EXCIPIENTS
・     TABLE 239           TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
・     TABLE 240           EXCIPIENTS USED IN PARENTERAL FORMULATIONS
・     TABLE 241           PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2020–2027 (USD MILLION)
・     TABLE 242           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 243           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 244           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8.5            OTHER FORMULATIONS
・     TABLE 245           PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS,
BY REGION, 2020–2027 (USD MILLION)
・     TABLE 246           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 214
・     TABLE 247           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 248           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 214

9      PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

9.1            INTRODUCTION
・     TABLE 249           PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION,
2020–2027 (USD MILLION)
9.2            EUROPE
・     FIGURE 34           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
・     TABLE 250           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 251           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 252           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 253           EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 254           EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 255           EUROPE: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 256           EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 257           EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 258           EUROPE: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 259           EUROPE: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 260           EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 261           EUROPE: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 262           EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 263           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 264           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 265           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 266           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 267           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.2.1               GERMANY
9.2.1.1             GERMANY ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET IN 2021
・     TABLE 268           GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 269           GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 270           GERMANY: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 271           GERMANY: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 272           GERMANY: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 273           GERMANY: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 274           GERMANY: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 275           GERMANY: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 276           GERMANY: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 277           GERMANY: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 278           GERMANY: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 279           GERMANY: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 280           GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 281           GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 282           GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2027 (USD MILLION)
・     TABLE 283           GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 284           GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,
BY TYPE, 2020–2027 (USD MILLION)
9.2.2               FRANCE
9.2.2.1             LARGE GERIATRIC POPULATION IN THE COUNTRY TO SUPPORT MARKET GROWTH
・     TABLE 285           FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 286           FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 287           FRANCE: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 288           FRANCE: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 289           FRANCE: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 290           FRANCE: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 291           FRANCE: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 292           FRANCE: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 293           FRANCE: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 294           FRANCE: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 295           FRANCE: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 296           FRANCE: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 297           FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 298           FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 299           FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 300           FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 301           FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.2.3               UK
9.2.3.1             GROWING ADOPTION OF GENERICS AND THE DEVELOPMENT OF NOVEL MULTI-FUNCTIONAL, CO-PROCESSED EXCIPIENTS TO DRIVE MARKET GROWTH
・     TABLE 302           UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 303           UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 304           UK: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 305           UK: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 306           UK: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 307           UK: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 308           UK: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 309           UK: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 310           UK: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 311           UK: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 312           UK: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 313           UK: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 314           UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 315           UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 316           UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 317           UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 318           UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,
2020–2027 (USD MILLION)
9.2.4               ITALY
9.2.4.1             BUDGETARY CONSTRAINTS AND RESTRICTED HEALTHCARE SPENDING IMPEDE THE GROWTH OF THE ITALIAN MARKET
・     TABLE 319           ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 320           ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 321           ITALY: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 322           ITALY: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 323           ITALY: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 324           ITALY: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 325           ITALY: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 326           ITALY: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 327           ITALY: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 328           ITALY: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 329           ITALY: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 330           ITALY: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 331           ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 332           ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 333           ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 334           ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 335           ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)

9.2.5               SPAIN
9.2.5.1             HIGH CONSUMPTION OF BIOLOGICS TO SUPPORT MARKET GROWTH
・     TABLE 336           SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 337           SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 338           SPAIN: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 339           SPAIN: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 340           SPAIN: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 341           SPAIN: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 342           SPAIN: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 343           SPAIN: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 344           SPAIN: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 345           SPAIN: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 346           SPAIN: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 347           SPAIN: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 348           SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 349           SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 350           SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 351           SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 352           SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.2.6               REST OF EUROPE

・     TABLE 353           ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 354           ROE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 355           ROE: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 356           ROE: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 357           ROE: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 358           ROE: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 359           ROE: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 360           ROE: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 361           ROE: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 362           ROE: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 363           ROE: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 364           ROE: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 365           ROE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 366           ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 367           ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 368           ROE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 369           ROE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.3            NORTH AMERICA
・     FIGURE 35           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
・     TABLE 370           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・     TABLE 371           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 372           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 373           NORTH AMERICA: OLEOCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 374           NORTH AMERICA: CARBOHYDRATES MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 375           NORTH AMERICA: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 376           NORTH AMERICA: ACTUAL SUGARS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 377           NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 378           NORTH AMERICA: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 379           NORTH AMERICA: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 380           NORTH AMERICA: PETROCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 381           NORTH AMERICA: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 382           NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 383           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 384           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 385           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY FORMULATION, 2020–2027 (USD MILLION)
・     TABLE 386           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 387           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.3.1               US
9.3.1.1             THE US DOMINATES THE NORTH AMERICAN MARKET
・     TABLE 388           US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 389           US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 390           US: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 391           US: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 392           US: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 393           US: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 394           US: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 395           US: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 396           US: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 397           US: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 398           US: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 399           US: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 400           US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 401           US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 402           US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 403           US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 404           US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,
2020–2027 (USD MILLION)
9.3.2               CANADA
9.3.2.1             STRONG GROWTH OF THE EMERGING MARKETS AND SLOWDOWN IN NEW PRODUCT APPROVALS HAMPER THE MARKET GROWTH IN CANADA
・     TABLE 405           CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 406           CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 407           CANADA: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 408           CANADA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 409           CANADA: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 410           CANADA: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 411           CANADA: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 412           CANADA: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 413           CANADA: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 414           CANADA: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 415           CANADA: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 416           CANADA: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 417           CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 418           CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 419           CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 420           CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 421           CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.4            ASIA PACIFIC
・     TABLE 422           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 423           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 424           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 425           ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 426           ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 427           ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 428           ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 429           ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 430           ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 431           ASIA PACIFIC: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 432           ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 433           ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 434           ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 435           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 436           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 437           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2027 (USD MILLION)
・     TABLE 438           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 439           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,
BY TYPE, 2020–2027 (USD MILLION)
9.4.1               JAPAN
9.4.1.1             THE RAPID GROWTH OF JAPAN’S GERIATRIC POPULATION WILL GREATLY DRIVE THE DEMAND FOR PHARMACEUTICALS
・     TABLE 440           JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 441           JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 442           JAPAN: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 443           JAPAN: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 444           JAPAN: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 445           JAPAN: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 446           JAPAN: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 447           JAPAN: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 448           JAPAN: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 449           JAPAN: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 450           JAPAN: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 451           JAPAN: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 452           JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 453           JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 454           JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 455           JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 456           JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.4.2               CHINA
9.4.2.1             EMPHASIS ON GENERICS AND OFF-PATENT DRUGS TO DRIVE THE MARKET IN CHINA
・     TABLE 457           CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 458           CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 459           CHINA: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 460           CHINA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 461           CHINA: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 462           CHINA: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 463           CHINA: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 464           CHINA: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 465           CHINA: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 466           CHINA: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 467           CHINA: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 468           CHINA: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 469           CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 470           CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 471           CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 472           CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 473           CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)

9.4.3               INDIA
9.4.3.1             INDIA IS A LEADING PRODUCER OF GENERICS
・     TABLE 474           INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 475           INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 476           INDIA: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 477           INDIA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 478           INDIA: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 479           INDIA: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 480           INDIA: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 481           INDIA: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 482           INDIA: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 483           INDIA: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 484           INDIA: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 485           INDIA: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 486           INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 487           INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION)
・     TABLE 488           INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 489           INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 490           INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.4.4               REST OF ASIA PACIFIC
・     TABLE 491           ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 492           ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 493           ROAPAC: OLEOCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 494           ROAPAC: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 495           ROAPAC: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 496           ROAPAC: ACTUAL SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 497           ROAPAC: SUGAR ALCOHOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 498           ROAPAC: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 499           ROAPAC: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 500           ROAPAC: PETROCHEMICALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 501           ROAPAC: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 502           ROAPAC: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 503           ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 504           ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 505           ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2027 (USD MILLION)
・     TABLE 506           ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 507           ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)
9.5            LATIN AMERICA
9.5.1               GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE ARE DRIVING MARKET GROWTH
・     TABLE 508           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 509           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 510           LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 511           LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 512           LATIN AMERICA: SUGARS MARKET, BY TYPE, 2020–2027 (USD MILLION)

・     TABLE 513      LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE,

2020–2027 (USD MILLION)
・     TABLE 514           LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 515           LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 516           LATIN AMERICA: STARCH MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 517           LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 518           LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 519           LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 520           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 521           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 522           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2027 (USD MILLION)
・     TABLE 523           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 524           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,
BY TYPE, 2020–2027 (USD MILLION)
9.6            MIDDLE EAST AND AFRICA
9.6.1               UNSATURATED MARKETS IN THE REGION HAVE DRAWN THE ATTENTION OF GLOBAL PLAYERS
・     TABLE 525           MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 526           MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 527           MIDDLE EAST & AFRICA: OLEOCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 528           MIDDLE EAST & AFRICA: CARBOHYDRATES MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 529           MIDDLE EAST & AFRICA: SUGARS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 530           MIDDLE EAST & AFRICA: ACTUAL SUGARS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 531           MIDDLE EAST & AFRICA: SUGAR ALCOHOLS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 532           MIDDLE EAST & AFRICA: CELLULOSE MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 533           MIDDLE EAST & AFRICA: STARCH MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 534           MIDDLE EAST & AFRICA: PETROCHEMICALS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 535           MIDDLE EAST & AFRICA: GLYCOLS MARKET, BY TYPE,
2020–2027 (USD MILLION)
・     TABLE 536           MIDDLE EAST & AFRICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 537           MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 538           MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY FUNCTIONALITY, 2020–2027 (USD MILLION)
・     TABLE 539           MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET,
BY FORMULATION, 2020–2027 (USD MILLION)
・     TABLE 540           MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR
ORAL FORMULATIONS, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 541           MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2020–2027 (USD MILLION)

10   COMPETITIVE LANDSCAPE

10.1          INTRODUCTION
10.2          RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
・     FIGURE 36           PHARMACEUTICAL EXCIPIENTS MARKET: STRATEGIES ADOPTED
10.3          MARKET SHARE ANALYSIS
・     FIGURE 37           PHARMACEUTICAL EXCIPIENTS MARKET: MARKET SHARE ANALYSIS
OF KEY PLAYERS (2021)
・     TABLE 542           PHARMACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION
10.4          REVENUE ANALYSIS
・     FIGURE 38           REVENUE ANALYSIS FOR KEY COMPANIES (2019-2021)
10.5          COMPANY EVALUATION QUADRANT
・     FIGURE 39           PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX, 2021
10.5.1             STARS
10.5.2             EMERGING LEADERS
10.5.3             PERVASIVE PLAYERS
10.5.4             PARTICIPANTS
10.6          COMPANY EVALUATION QUADRANT: START-UPS/SMES
・     FIGURE 40           PHARMACEUTICAL EXCIPIENTS MARKET:
COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021
10.6.1             PROGRESSIVE COMPANIES
10.6.2             STARTING BLOCKS
10.6.3             RESPONSIVE COMPANIES
10.6.4             DYNAMIC COMPANIES
10.7          COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
・     TABLE 543           PHARMACEUTICAL EXCIPIENTS MARKET:
DETAILED LIST OF KEY START-UPS/SMES
・     TABLE 544           PHARMACEUTICAL EXCIPIENTS MARKET:
COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES] 333
10.8          COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
10.8.1             COMPANY FOOTPRINT ANALYSIS (25 COMPANIES)
・     TABLE 545           COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
10.8.2             COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
・     TABLE 546           PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
10.8.3             COMPANY FUNCTIONALITY FOOTPRINT (25 COMPANIES)
・     TABLE 547           FUNCTIONALITY FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET
10.8.4             COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
・     TABLE 548           REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
10.9          COMPETITIVE SCENARIO AND TRENDS
10.9.1             PRODUCT LAUNCHES  338
・     TABLE 549           PHARMACEUTICAL EXCIPIENTS MARKET:
PRODUCT LAUNCHES, JANUARY 2019-MAY 2022
10.9.2             DEALS
・     TABLE 550           PHARMACEUTICAL EXCIPIENTS MARKET: DEALS, JANUARY 2019-MAY 2022

11   COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
11.1          KEY PLAYERS
11.1.1             INTERNATIONAL FLAVORS & FRAGRANCES INC.
・     TABLE 551           INTERNATIONAL FLAVORS & FRAGRANCES, INC.: BUSINESS OVERVIEW
・     FIGURE 41           INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
11.1.2             ASHLAND GLOBAL HOLDINGS INC
・     TABLE 552           ASHLAND: BUSINESS OVERVIEW   344
・     FIGURE 42           ASHLAND: COMPANY SNAPSHOT
11.1.3             EVONIK INDUSTRIES AG
・     TABLE 553           EVONIK INDUSTRIES: BUSINESS OVERVIEW
・     FIGURE 43           EVONIK INDUSTRIES: COMPANY SNAPSHOT
11.1.4             BASF SE
・     TABLE 554           BASF SE.: BUSINESS OVERVIEW   352
・     FIGURE 44           BASF SE.: COMPANY SNAPSHOT  353
11.1.5             KERRY GROUP PLC  356
・     TABLE 555           KERRY GROUP: BUSINESS OVERVIEW
・     FIGURE 45           KERRY GROUP: COMPANY SNAPSHOT
11.1.6             ROQUETTE FRÈRES  359
・     TABLE 556           ROQUETTE FRÈRES: BUSINESS OVERVIEW
11.1.7             MERCK KGAA
・     TABLE 557           MERCK KGAA: BUSINESS OVERVIEW
・     FIGURE 46           MERCK KGAA: COMPANY SNAPSHOT  362
11.1.8             ASSOCIATED BRITISH FOODS PLC
・     TABLE 558           ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
・     FIGURE 47           ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
11.1.9             ARCHER DANIELS MIDLAND (ADM) COMPANY
・     TABLE 559           ARCHER DANIELS MIDLAND (ADM) COMPANY: BUSINESS OVERVIEW
・     FIGURE 48           ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
11.1.10          WACKER CHEMIE AG
・     TABLE 560           WACKER CHEMIE AG: BUSINESS OVERVIEW
・     FIGURE 49           WACKER CHEMIE AG: COMPANY SNAPSHOT
11.1.11          AIR LIQUIDE SA
・     TABLE 561           AIR LIQUIDE: BUSINESS OVERVIEW
・     FIGURE 50           AIR LIQUIDE SA: COMPANY SNAPSHOT
11.1.12          DOW CHEMICALS
・     TABLE 562           DOW CHEMICALS: BUSINESS OVERVIEW
・     FIGURE 51           DOW CHEMICALS: COMPANY SNAPSHOT
11.2          OTHER PLAYERS
11.2.1             LUBRIZOL CORPORATION
11.2.2             COLORCON, INC
11.2.3             DMV-FONTERRA EXCIPIENTS GMBH & CO. KG
11.2.4             INNOPHOS HOLDINGS, INC
11.2.5             JRS PHARMA GMBH & CO. KG
11.2.6             FINAR LIMITED
11.2.7             MEGGLE GMBH & CO. KG
11.2.8             FUJI CHEMICAL INDUSTRIES CO., LTD.
11.2.9             CAPTISOL
11.2.10          IDEAL CURES PVT. LTD.
11.2.11          COREL PHARMA CHEM   383
11.2.12          BIOGRUND GMBH
11.2.13          NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12   APPENDIX


△ 一番上に戻る